UCRAID (Ukrainian Citizen and refugee electronic support in Respiratory diseases, Allergy, Immunology and Dermatology) action plan.
Ukrainian refugees
asthma
mHealth
rhinitis
urticaria
Journal
Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
revised:
26
07
2023
received:
26
06
2023
accepted:
08
08
2023
pubmed:
29
8
2023
medline:
29
8
2023
entrez:
29
8
2023
Statut:
ppublish
Résumé
Eight million Ukrainians have taken refuge in the European Union. Many have asthma and/or allergic rhinitis and/or urticaria, and around 100,000 may have a severe disease. Cultural and language barriers are a major obstacle to appropriate management. Two widely available mHealth apps, MASK-air® (Mobile Airways Sentinel NetworK) for the management of rhinitis and asthma and CRUSE® (Chronic Urticaria Self Evaluation) for patients with chronic spontaneous urticaria, were updated to include Ukrainian versions that make the documented information available to treating physicians in their own language. The Ukrainian patients fill in the questionnaires and daily symptom-medication scores for asthma, rhinitis (MASK-air) or urticaria (CRUSE) in Ukrainian. Then, following the GDPR, patients grant their physician access to the app by scanning a QR code displayed on the physician's computer enabling the physician to read the app contents in his/her own language. This service is available freely. It takes less than a minute to show patient data to the physician in the physician's web browser. UCRAID-developed by ARIA (Allergic Rhinitis and its Impact on Asthma) and UCARE (Urticaria Centers of Reference and Excellence)-is under the auspices of the Ukraine Ministry of Health as well as European (European Academy of Allergy and Clinical immunology, EAACI, European Respiratory Society, ERS, European Society of Dermatologic Research, ESDR) and national societies.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2581-2595Subventions
Organisme : MASK-air SAS
Organisme : MOXIE
Informations de copyright
© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Références
Bousquet J, Michel J, Standberg T, Crooks G, Iakovidis I, Gomez M. The European innovation partnership on active and healthy ageing: the European geriatric medicine introduces the EIP on AHA column. Eur Geriatr Med. 2014;5(6):361-362.
Bousquet J, Addis A, Adcock I, et al. Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014;44(2):304-323. doi:10.1183/09031936.00014614
Bousquet J, Barbara C, Bateman E, et al. AIRWAYS-ICPs (European innovation partnership on active and healthy ageing) from concept to implementation. Eur Respir J. 2016;47(4):1028-1033. doi:10.1183/13993003.01856-2015
Yorgancioglu A, Khaltaev N, Bousquet J, Varghese C. The global alliance against chronic respiratory diseases: journey so far and way ahead. Chin Med J. 2020;133:1513-1515. doi:10.1097/CM9.0000000000000851
Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;63(Suppl 86):8-160. doi:10.1111/j.1398-9995.2007.01620.x
Bousquet J, Hellings PW, Agache I, et al. ARIA 2016: care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. Clin Transl Allergy. 2016;6:47. doi:10.1186/s13601-016-0137-4
Bousquet J, Anto JM, Bachert C, et al. From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity. Eur Respir J. 2019;54(6):1901023. doi:10.1183/13993003.01023-2019
Maurer M, Metz M, Bindslev-Jensen C, et al. Definition, aims, and implementation of GA2LEN urticaria centers of reference and excellence. Allergy. 2016;71:1210-1218. doi:10.1111/all.12901
Kocaturk E, Al-Ahmad M, Krause K, et al. Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: results of PREG-CU, a UCARE study. J Eur Acad Dermatol Venereol. 2023;37(2):356-364. doi:10.1111/jdv.18574
Bizjak M, Kosnik M, Dinevski D, et al. Risk factors for systemic reactions in typical cold urticaria: results from the COLD-CE study. Allergy. 2022;77(7):2185-2199. doi:10.1111/all.15194
Cherrez-Ojeda I, Vanegas E, Cherrez A, et al. How are patients with chronic urticaria interested in using information and communication technologies to guide their healthcare? A UCARE study. World Allergy Organ J. 2021;14(6):100542. doi:10.1016/j.waojou.2021.100542
Murphy A, Bartovic J, Bogdanov S, et al. Meeting the long-term health needs of Ukrainian refugees. Public Health. 2023;220:96-98. doi:10.1016/j.puhe.2023.04.015
Dumitrache L, Nae M, Mareci A, Tudoricu A, Cioclu A, Velicu A. Experiences and perceived barriers of asylum seekers and people with refugee backgrounds in accessing healthcare services in Romania. Healthcare. 2022;10(11):2162. doi:10.3390/healthcare10112162
Deps P, Charlier P. Medical approach to refugees: importance of the caring physician. Ann Glob Health. 2020;86(1):41. doi:10.5334/aogh.2779
Ludvigsson JF, Loboda A. Reviewing child health in Ukraine: the use of preprints and older data and the role of impact factors. Acta Paediatr. 2022;111(12):2426-2427. doi:10.1111/apa.16566
Lee ACK, Khaw FM, Lindman AES, Juszczyk G. Ukraine refugee crisis: evolving needs and challenges. Public Health. 2023;217:41-45. doi:10.1016/j.puhe.2023.01.016
Warenczak-Florczak Z, Urbanski B. What challenges does the humanitarian crisis and large number of refugees from Ukraine pose for polish oncology? Rep Pract Oncol Radiother. 2022;27(3):566-570. doi:10.5603/RPOR.a2022.0051
UNHCR. The UN refugee agency, Integration handbook. 2023. Accessed July 8, 2023. https://wwwunhcrorg/handbooks/ih/health/health-care
Poppleton A, Ougrin D, Maksymets Y. Providing responsive primary care for Ukrainian refugees. Br J Gen Pract. 2022;72(719):274-275. doi:10.3399/bjgp22X719633
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Advances and highlights in asthma in 2021. Allergy. 2021;76(11):3390-3407. doi:10.1111/all.15054
Kamoun PD, Prasad P, Durieux-Paillard S. Ukrainians refugees: how to address their health needs in times of migration crisis? Rev Med Suisse. 2023;19(834):1298-1304. Refugies d'Ukraine: comment repondre a leurs besoins de sante en periode de crise migratoire? doi:10.53738/REVMED.2023.19.834.1298
Jain N, Prasad S, Bordeniuc A, et al. European countries step-up humanitarian and medical assistance to Ukraine as the conflict continues. J Prim Care Community Health. 2022;13:21501319221095358. doi:10.1177/21501319221095358
Aljadeeah S, Michielsen J, Ravinetto R, et al. Facilitating access to medicines and continuity of care for Ukrainian refugees: exceptional response or the promise of more inclusive healthcare for all migrants? BMJ Glob Health. 2022;7(8):e010327. doi:10.1136/bmjgh-2022-010327
Piotrowicz K, Semeniv S, Kupis R, et al. Disease burden in older Ukrainian refugees of war: a synthetic reanalysis of public records data. Lancet Healthy Longev. 2022;3(10):e667-e673. doi:10.1016/S2666-7568(22)00187-8
Marchese V, Formenti B, Cocco N, et al. Examining the pre-war health burden of Ukraine for prioritisation by European countries receiving Ukrainian refugees. Lancet Reg Health Eur. 2022;15:100369. doi:10.1016/j.lanepe.2022.100369
Spiegel PB. Are the health systems of EU countries hosting Ukrainian refugees ready to adapt? Lancet Healthy Longev. 2022;3(10):e639-e640. doi:10.1016/S2666-7568(22)00197-0
mHealth. New horizons for health through mobile technologies. Global Observatory for eHealth series-Vol 3 WHO Library Cataloguing-in-Publication Data. 2011. Accessed August 20, 2023. https://apps.who.int/iris/handle/10665/44607
Plaza Roncero A, Marques G, Sainz-De-Abajo B, et al. Mobile health apps for medical emergencies: systematic review. JMIR Mhealth Uhealth. 2020;8(12):e18513. doi:10.2196/18513
Bousquet J, Bedbrook A, Czarlewski W, et al. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma. Clin Transl Allergy. 2019;9:16. doi:10.1186/s13601-019-0252-0
Bousquet J, Hellings PW, Agache I, et al. Allergic rhinitis and its impact on asthma (ARIA) phase 4 (2018): change management in allergic rhinitis and asthma multimorbidity using mobile technology. J Allergy Clin Immunol. 2019;143(3):864-879. doi:10.1016/j.jaci.2018.08.049
Russian language knowledge in Europe. 2022. Accessed July 8, 2023. https://www.languageknowledge.eu/languages/russian
Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®. Clin Transl Allergy. 2021;11(7):e12062. doi:10.1002/clt2.12062
Bousquet J, Anto JM, Sousa-Pinto B, et al. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: the ARIA-MASK-air® approach. Clin Transl Allergy. 2023;13(1):e12215. doi:10.1002/clt2.12215
Sousa-Pinto B, Anto A, Berger M, et al. Real-world data using mHealth apps in rhinitis, rhinosinusitis and their multimorbidities. Clin Transl Allergy. 2022;12(11):e12208. doi:10.1002/clt2.12208
Sousa-Pinto B, Fonseca JA, Gemicioglu B, et al. Patient-reported outcome measures (PROMs) using the MASK-air® app in severe asthma. Allergy. 2022;77(5):1600-1602. doi:10.1111/all.15248
Bedard A, Anto JM, Fonseca JA, et al. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air® app. Allergy. 2020;75(7):1672-1688. doi:10.1111/all.14204
Vieira RJ, Pham-Thi N, Anto JM, et al. Academic productivity of young people with allergic rhinitis: a MASK-air study. J Allergy Clin Immunol Pract. 2022;10(11):3008-3017.e4. doi:10.1016/j.jaip.2022.08.015
Sousa-Pinto B, Sa-Sousa A, Amaral R, et al. Assessment of the control of allergic rhinitis and asthma test (CARAT) using MASK-air. J Allergy Clin Immunol Pract. 2022;10(1):343-345.e2. doi:10.1016/j.jaip.2021.09.012
Vieira RJ, Sousa-Pinto B, Cardoso-Fernandes A, et al. Control of allergic rhinitis and asthma test: a systematic review of measurement properties and COSMIN analysis. Clin Transl Allergy. 2022;12(9):e12194. doi:10.1002/clt2.12194
Sofiev M, Palamarchuk Y, Bedard A, et al. A demonstration project of global alliance against chronic respiratory diseases: prediction of interactions between air pollution and allergen exposure-the mobile airways sentinel NetworK-impact of air POLLution on asthma and rhinitis approach. Chin Med J. 2020;133(13):1561-1567. doi:10.1097/CM9.0000000000000916
Sousa-Pinto B, Azevedo LF, Jutel M, et al. Development and validation of combined symptom-medication scores for allergic rhinitis. Allergy. 2022;77(7):2147-2162. doi:10.1111/all.15199
Sousa-Pinto B, Jacome C, Pereira A, et al. Development and validation of an electronic daily control score for asthma (e-DASTHMA). Lancet Digit Health. 2023;5:e227-e238.
Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. doi:10.1111/all.15090
Kotter J. Leading Change. Harvard Business School Press; 1996.
Bousquet J, Schunemann HJ, Samolinski B, et al. Allergic rhinitis and its impact on asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol. 2012;130(5):1049-1062. doi:10.1016/j.jaci.2012.07.053
Bousquet J, Burney PG, Zuberbier T, et al. GA2LEN (global allergy and asthma European network) addresses the allergy and asthma ‘epidemic’. Allergy. 2009;64(7):969-977. doi:10.1111/j.1398-9995.2009.02059.x
Mahmud AJ, Olander E, Eriksen S, Haglund BJ. Health communication in primary health care-a case study of ICT development for health promotion. BMC Med Inform Decis Mak. 2013;13:17. doi:10.1186/1472-6947-13-17
Sousa-Pinto B, Sa-Sousa A, Vieira RJ, et al. Cut-off values of MASK-air® patient-reported outcome measures (PROMs). J Allergy Clin Immunol Pract. 2022;11:1281-1289. doi:10.1016/j.jaip.2022.12.005.e5.
Ventura MT, Giuliano AFM, Buquicchio R, et al. Implementation of the MASK-air® app for rhinitis and asthma in older adults: MASK@Puglia pilot study. Int Arch Allergy Immunol. 2022;183(1):45-50. doi:10.1159/000518032
Taborda-Barata L, Ventura MT, Blain H, et al. MASK-air® real-world data in respiratory allergy in old-age adults. Clin Transl Allergy. 2023;13(1):e12216. doi:10.1002/clt2.12216
Laune D, Arnavielhe S, Viart F, et al. Adaptation of the general data protection regulation (GDPR) to a smartphone app for rhinitis and asthma (MASK-air®). Rev Mal Respir. 2019;36(9):1019-1031. Reglement general sur la protection des donnees pour MASK-air® (application mobile rhinite et asthme). doi:10.1016/j.rmr.2019.08.003
Samreth D, Arnavielhe S, Ingenrieth F, et al. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organ J. 2018;11(1):15. doi:10.1186/s40413-018-0194-3
Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 93/42/EEC. 2017. Accessed July 8, 2023. https://eur-lexeuropaeu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0745
Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 - MDR and Regulation (EU) 2017/746 - IVDR. October, 2019. Accessed July 8, 2023. https://wwwgooglecom/search?client=safari&rls=en&q=MDCG+2019-11&ie=UTF-8&oe=UTF-8